. Show Affiliations »
Abstract
Entities: Chemical Disease
Mesh： See more » AdultChildDrug ApprovalHIV Infections/drug therapyHIV Integrase Inhibitors/administration & dosageHIV Integrase Inhibitors/adverse effectsHIV Integrase Inhibitors/therapeutic useHeterocyclic Compounds, 3-Ring/administration & dosageHeterocyclic Compounds, 3-Ring/adverse effectsHeterocyclic Compounds, 3-Ring/therapeutic useHumansUnited StatesUnited States Food and Drug Administration
Substances： See more » HIV Integrase InhibitorsHeterocyclic Compounds, 3-Ringdolutegravir
Year: 2013 PMID： 24081387
Source DB: PubMed Journal: Med Lett Drugs Ther ISSN： 0025-732X Impact factor: 1.909